1. Home
  2. FHI vs LIVN Comparison

FHI vs LIVN Comparison

Compare FHI & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federated Hermes Inc.

FHI

Federated Hermes Inc.

HOLD

Current Price

$54.02

Market Cap

4.0B

Sector

Finance

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$63.22

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHI
LIVN
Founded
1955
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.5B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
FHI
LIVN
Price
$54.02
$63.22
Analyst Decision
Buy
Strong Buy
Analyst Count
7
8
Target Price
$49.00
$65.00
AVG Volume (30 Days)
643.0K
656.1K
Earning Date
01-29-2026
11-05-2025
Dividend Yield
2.54%
N/A
EPS Growth
50.93
N/A
EPS
4.77
N/A
Revenue
$1,742,513,000.00
$1,348,962,000.00
Revenue This Year
$10.23
$12.25
Revenue Next Year
$6.95
$6.75
P/E Ratio
$11.22
N/A
Revenue Growth
8.98
8.63
52 Week Low
$35.05
$32.48
52 Week High
$54.42
$65.57

Technical Indicators

Market Signals
Indicator
FHI
LIVN
Relative Strength Index (RSI) 71.00 61.02
Support Level $51.88 $61.79
Resistance Level $53.56 $63.32
Average True Range (ATR) 1.10 1.50
MACD 0.27 -0.36
Stochastic Oscillator 91.03 38.85

Price Performance

Historical Comparison
FHI
LIVN

About FHI Federated Hermes Inc.

Federated Hermes provides asset-management services for institutional and individual investors. The firm had $843.7 billion in managed assets at the end of June 2025, composed of equity (10%), multi-asset (less than 1%), fixed-income (12%), alternative (2%), and money market (75%) funds. The firm's cash-management operations are expected to generate around 52% of Federated's revenue this year, compared with 29%, 11%, and 8%, respectively, for the equity, fixed-income, and alternatives/multi-asset/other operations. The company's products are distributed via trust banks, wealth managers, and retail broker/dealers (67% of AUM), institutional investors (26%), and international clients (7%).

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: